RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mahesh Lakshman to Hydroxylamines

Back to Details
This is a "connection" page, showing publications Mahesh Lakshman has written about Hydroxylamines.
Mahesh Lakshman
Connection Strength
0.239
Hydroxylamines
  1. Persaud KE, Sahu RR, Neary MC, Kapdi AR, Lakshman MK. Two short approaches to the COVID-19 drug ?-D-N4-hydroxycytidine and its prodrug molnupiravir. Org Biomol Chem. 2024 01 24; 22(4):735-740.
    View in: PubMed
    Score: 0.239
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support